ViaDerma Inc (VDRM)

[gameccks1]

1Q24 Report (due May 15th or May 20th with extension)
1) Hopefully, it will be the first quarterly issued on time since 1Q22, maintaining Pink Current status (credibility and reputation)
2) Hopefully, it will document receipt of $1.2M of back licensing fees (credibility and reputation)
3) Hopefully, it will document 14 states worth of licensing fees ($210K for quarter) in alignment with 10/24/23 PR. (credibility and reputation)
4) Hopefully, it will document increase from trickle of online sales.